BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36456179)

  • 21. The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.
    Yoshimoto D; Nakano Y; Onishi K; Hagan G; Jones P
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1357-63. PubMed ID: 25525353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung function impairment in the German Lung Cancer Screening Intervention Study (LUSI): prevalence, symptoms, and associations with lung cancer risk, tumor histology and all-cause mortality.
    Kaaks R; Christodoulou E; Motsch E; Katzke V; Wielpütz MO; Kauczor HU; Heussel CP; Eichinger M; Delorme S
    Transl Lung Cancer Res; 2022 Sep; 11(9):1896-1911. PubMed ID: 36248328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity.
    Harvey BG; Strulovici-Barel Y; Kaner RJ; Sanders A; Vincent TL; Mezey JG; Crystal RG
    Eur Respir J; 2015 Dec; 46(6):1589-1597. PubMed ID: 26541521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy.
    Young RP; Duan F; Chiles C; Hopkins RJ; Gamble GD; Greco EM; Gatsonis C; Aberle D
    Am J Respir Crit Care Med; 2015 Nov; 192(9):1060-7. PubMed ID: 26199983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient-reported respiratory symptoms and pre-bronchodilator airflow limitation among smokers in Switzerland.
    Miedinger D; Linz A; Praehauser C; Chhajed PN; Buess C; Schafroth Török S; Bucher HC; Tamm M; Leuppi JD
    Prim Care Respir J; 2010 Jun; 19(2):163-9. PubMed ID: 20514390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience.
    de-Torres JP; Alcaide AB; Campo A; Zulueta JJ; Bastarrika G; Ezponda A; Mesa M; Murillo D; Rodriguez M; Del Mar Ocón M; Felgueroso C; Pueyo J; Lozano MD; Montuenga LM; Berto J; Perez-Warnisher MT; Di-Frisco IM; Seijo LM
    Arch Bronconeumol; 2024 Feb; 60(2):95-100. PubMed ID: 38216404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep Learning Using Chest Radiographs to Identify High-Risk Smokers for Lung Cancer Screening Computed Tomography: Development and Validation of a Prediction Model.
    Lu MT; Raghu VK; Mayrhofer T; Aerts HJWL; Hoffmann U
    Ann Intern Med; 2020 Nov; 173(9):704-713. PubMed ID: 32866413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel.
    Stav D; Raz M
    Isr Med Assoc J; 2007 Nov; 9(11):800-2. PubMed ID: 18085037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occupational exposure to vapor, gas, dust, or fumes and chronic airflow limitation, COPD, and emphysema: the Swedish CArdioPulmonary BioImage Study (SCAPIS pilot).
    Torén K; Vikgren J; Olin AC; Rosengren A; Bergström G; Brandberg J
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3407-3413. PubMed ID: 29238185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The PLATINO study: description of the distribution, stability, and mortality according to the Global Initiative for Chronic Obstructive Lung Disease classification from 2007 to 2017.
    Menezes AM; Wehrmeister FC; Perez-Padilla R; Viana KP; Soares C; Müllerova H; Valdivia G; Jardim JR; Montes de Oca M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1491-1501. PubMed ID: 28553101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Features of COPD as Predictors of Lung Cancer.
    Carr LL; Jacobson S; Lynch DA; Foreman MG; Flenaugh EL; Hersh CP; Sciurba FC; Wilson DO; Sieren JC; Mulhall P; Kim V; Kinsey CM; Bowler RP
    Chest; 2018 Jun; 153(6):1326-1335. PubMed ID: 29452098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Medication Intensity and Stages of Airflow Limitation With the Risk of Hospitalization or Death in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease.
    Lawson CA; Mamas MA; Jones PW; Teece L; McCann G; Khunti K; Kadam UT
    JAMA Netw Open; 2018 Dec; 1(8):e185489. PubMed ID: 30646293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Airflow limitation and survival after surgery for non-small cell lung cancer: Results from a systematic review and lung cancer screening trial (NLST-ACRIN sub-study).
    Hopkins RJ; Ko J; Gamble GD; Young RP
    Lung Cancer; 2019 Sep; 135():80-87. PubMed ID: 31447006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic significance of lung function in stable heart failure outpatients.
    Plesner LL; Dalsgaard M; Schou M; Køber L; Vestbo J; Kjøller E; Iversen K
    Clin Cardiol; 2017 Nov; 40(11):1145-1151. PubMed ID: 28902960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the Impact of Lung Cancer Screening on Lung Cancer Mortality of Smokers With Obstructive Lung Disease: Analysis of the NLST-ACRIN Cohort.
    de-Torres JP; Wisnivesky JP; Bastarrika G; Wilson DO; Celli BR; Zulueta JJ
    Arch Bronconeumol (Engl Ed); 2021 Jan; 57(1):36-41. PubMed ID: 32409195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associated Factors and Comorbidities of Airflow Limitation in Subjects Undergoing Comprehensive Health Examination in Japan - Survey of Chronic Obstructive Pulmonary Disease Patients Epidemiology in Japan (SCOPE- J).
    Omori H; Higashi N; Nawa T; Fukui T; Kaise T; Suzuki T
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3039-3050. PubMed ID: 33262583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum-based biomarkers associated with lung cancer risk and cause-specific mortality in the German randomized Lung Cancer Screening Intervention (LUSI) trial.
    Cortés-Ibáñez FO; Johnson T; Mascalchi M; Katzke V; Delorme S; Kaaks R
    Transl Lung Cancer Res; 2023 Dec; 12(12):2460-2475. PubMed ID: 38205209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features of lung cancer in smokers with light and mild chronic obstructive pulmonary disease: a retrospective analysis of Japanese surgical cases.
    Kondo R; Yoshida K; Eguchi T; Kobayashi N; Saito G; Hamanaka K; Shiina T; Kurai M
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1439-43. PubMed ID: 21530296
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.